Page last updated: 2024-10-27

flutamide and Porphyria Cutanea Tarda

flutamide has been researched along with Porphyria Cutanea Tarda in 1 studies

Flutamide: An antiandrogen with about the same potency as cyproterone in rodent and canine species.

Porphyria Cutanea Tarda: An autosomal dominant or acquired porphyria due to a deficiency of UROPORPHYRINOGEN DECARBOXYLASE in the LIVER. It is characterized by photosensitivity and cutaneous lesions with little or no neurologic symptoms. Type I is the acquired form and is strongly associated with liver diseases and hepatic toxicities caused by alcohol or estrogenic steroids. Type II is the familial form.

Research Excerpts

ExcerptRelevanceReference
"Flutamide is an antiandrogen used for the treatment of prostatic carcinoma."1.30[Flutamide-induced late cutaneous pseudoporphyria]. ( Bahadoran, P; Bermon, C; Lacour, JP; Mantoux, F; Ortonne, JP; Perrin, C, 1999)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mantoux, F1
Bahadoran, P1
Perrin, C1
Bermon, C1
Lacour, JP1
Ortonne, JP1

Other Studies

1 other study available for flutamide and Porphyria Cutanea Tarda

ArticleYear
[Flutamide-induced late cutaneous pseudoporphyria].
    Annales de dermatologie et de venereologie, 1999, Volume: 126, Issue:2

    Topics: Aged; Androgen Antagonists; Biopsy; Diagnosis, Differential; Fluorescent Antibody Technique; Flutami

1999